JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Issues journals
Medical Radiology and Radiation Safety. 2024. Vol. 69. № 4
DOI:10.33266/1024-6177-2024-69-4-55-61
F.S. Torubarov, M.V. Kuleshova, N.A. Metlyaeva, S.N. Lukyanova, L.A. Yunanova
Phenomenology and Number of Neurological Manifestations in Liquidators of The Consequences of the Accident at the Chernobyl Npp with Low Doses of Ionizing Radiation and Observation Period
A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: N.A. Metlyaeva, , e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Purpose: To analyze our own data on the dependence of neurological manifestations in liquidators of the Chernobyl accident on the dose within low values and observation time after irradiation.
Material and methods: The study was conducted with the participation of 141 liquidators of the consequences of a nuclear power plant accident. The analysis used clinical data on the nosology of neurological manifestations, which are presented in comparison with low radiation doses (31±6 and 190±22 mSv) and observation time after the accident (1986‒1988). The results are statistically substantiated.
Results: It was shown that there is no direct relationship between the incidence of neurological disorders and the dose of ionizing radiation within low values. On the contrary, a statistically significant predominance of their number was noted at lower doses – 31±6, relative to 190±22 mSv. The main phenomenology was reduced to neurocirculatory dystonia. The prevalence of vegetative-vascular dystonia and encephalopathy was almost the same during different periods of operation at the Chernobyl NPP and was always statistically significantly lower than the neurocirculatory dystonia. These data were correlated with the type of EEG activity.
Conclusion: The effects of low doses of ionizing radiation (31±6 and 190±22 mSv) during various periods of observation (1986‒1988) were characterized by a quantitative predominance of nosological forms in the form of neurocirculatory dystonia. Statistically significant, in a greater percentage of cases they were noted at lower doses (35.7 %, relatively, 18.7 % at higher doses). Analysis of observation periods of the effects of low doses confirms these data and represents the likelihood of their intensification in long-term observation periods:
1986 – 24.4 %, 1988 – 35.7 %, whereas at higher doses these changes were noted only in 1986 – 18.7 %.
Keywords: accident at the Chernobyl NPP, liquidators, neurocirculatory dystonia, vegetative-vascular dystonia, encephalopathy, electroencephalography
For citation: Torubarov FS, Kuleshova MV, Metlyaeva NA, Lukyanova SN, Yunanova LA. Phenomenology and Number of Neurological Manifestations in Liquidators of the Consequences of the Accident at the Chernobyl Npp with Low Doses of Ionizing Radiation and Observation Period. Medical Radiology and Radiation Safety. 2024;69(4):55–61. (In Russian). DOI:10.33266/1024-6177-2024-69-4-55-61
References
1. Guskova AK. Radiation and the human brain. Current and predicted mental health disorders after the Chernobyl nuclear disaster. Proceedings of the international conference. Kyiv. 1985. p. 22. (In Russ.).
2. Budunov VA, Strapko NP, Pirogova EA. Scientific and practical aspects of preserving the health of people exposed to radiation as a result of the accident at the Chernobyl nuclear power plant. Minsk. 1991, P. 168-169. (In Russ.).
3. Zozulya AE., Polishchuk IE., Korol SA. Scientific and practical aspects of preserving the health of people exposed to radiation as a result of the accident at the Chernobyl nuclear power plant. Minsk, 1991, P. 171-173. (In Russ.).
4. Vereshchagin NV, Bratina LK, Vavilov SB et al. Computed tomography of the brain. M.: Medicine. 1986. p. 251. (In Russ.).
5. Kholodova TB. Changes in the central nervous system of liquidators of the consequences of the accident at the Chernobyl nuclear power plant. (according to clinical and X-ray data) Journal of Neurology and Psychiatry. 1993:93(4):74-77. (In Russ.).
6. Torubarov FS, Kuleshova MV, Lukyanova SN, Zvereva ZV, Samoilov AS. Spectral-correlation analysis of EEG in liquidators of the Chernobyl accident with neurological disorders. Medical Radiology and Radiation Safety. 2019:64(3):40-45. (In Russ.).
7. Nyagu AI. Long-term psychoneurological consequences of the accident at the Chernobyl nuclear power plant: results and priority directions. International conference “Current and predictable mental health disorders after a nuclear disaster in Chernobyl.” May 24-28, 1995. Kyiv. p. 30. (In Russ.).
8. Guskova AK. Radiation: imaginary and real dangers (regulatory and methodological materials on radiation medicine of the USSR Ministry of Health). Moscow. 1990. p. 5-11. (In Russ.).
9. Aleksandrovsky YuA, Rumyantseva GM, Shchukin BP, Yurov VV. Journal of Neuropathology and Psychiatry, 1989(5):111-117. (In Russ.).
10. Aleksandrovsky YuA, Shchukin BP. Journal Neuropathology and Psychiatry. 1991(5):39-43. (In Russ.).
11. Nechiporenko VV, Rudoy IS, Sofronyeva NM, Sergienko AV. VIII CONGRESS of neuropathologists, psychiatrists and narcologists of Ukraine RSR. Kharkov, 1990:4(2):349-350.
12. Saprun NP. VIII CONGRESS of neuropathologists, psychiatrists and narcologists of Ukraine RSR. Kharkov, 1990:4(2):350-351.
13. Panchenko OA. Maladaptive states in participants of the emergency response at the Chernobyl nuclear power plant. Ukrainian Herald of Psychoneurology. 1995:3(2):190-191.
14. Burtyansky DL. Some clinical features of modern neuroses depending on the causes and conditions of their development. Collection of scientific papers. USSR Academy of Sciences. Institute of Psychology. M.: 1991. P. 186-188. (In Russ.).
15. Isurina GL. Mechanisms of psychological correction of personality in the process of group psychotherapy for neuropsychiatric diseases. L.: 1988. 4. Yerevan. 1973. p. 77. (In Russ.).
16. Sivachenko VN, Zenevich MV, Garbuz LA. Mechanisms of development of pathology and its structure under the influence of small doses of radiation on the human body. Radioactivity and radioactive elements in the human environment: Abstracts of reports. Tomsk. 1996. P. 328-331.
17. Zdesenko IV. Stages of development of cerebrovascular disorders in persons exposed to radiation as a result of the Chernobyl accident. International conference. (In Russ.).
18. Novikov BS. The intensity of the body’s defensive reactions during psycho-emotional stress. Eighth All-Union Congress of Neuropathologists, Psychiatrists and Narcologists. Abstract report, 25-28 Oct. Moscow. 1988. Volume 3. P. 356-357. (In Russ.).
19. Krasnov VN, Yurkin MM, Voitsekh VF, Skavysh VA, Gorobets LN, Zubovsky GA et al. Mental disorders among participants in the liquidation of the consequences of the accident at the Chernobyl nuclear power plant. Social and clinical psychiatry, 1993:(1):5-10. (In Russ.).
20. Vein AM. Diseases of the autonomic nervous system. M.: Medicine, 1991. P. 39-51. (In Russ.).
21. Larionova I.K. Functional changes in the central nervous system under the combined influence of external radiation and incorporated plutonium-239 in small doses. Radiation Medicine Bulletins. 1982(3):115-121. (In Russ.).
22. Nyagu AI, Noshchenko AG, Loganovsky KN. Long-term consequences of psychogenic and radiation factors of the accident at the Chernobyl nuclear power plant on the functional states of the human brain. Journal of Neurology and Psychiatry. 1992:(4):72-77. (In Russ.).
23. Denisevich NK. Clinical and epidemiological studies to identify diseases of the nervous system among the population constantly living in conditions of increased ionizing radiation. All-Union scientific conference “Changes in the human nervous system under the influence of ionizing radiation”: Abstracts of reports. Moscow. 1989. P. 110-114. (In Russ.).
24. Wayne AM. Classification of autonomic disorders. Journal Neuropathology and Psychiatry. 1988: (10):9-12. (In Russ.).
25. Zhirmunskaya EA. Clinical electroencephalography. M.: 1991. p. 77. (In Russ.).
26. Kochanova EM. The state of blood circulation in persons with neurocirculatory dystonia syndrome exposed to ionizing radiation in professional conditions. Dissertation of Candidate of Medical Sciences. M.: 1976. p. 140. (In Russ.).
27. Dakhno DV. Study of the state of the autonomic nervous system in individuals who took part in the Chernobyl nuclear accident. Dissertation of Candidate of Medical Sciences. M.: 1990.
P. 145-154. (In Russ.).
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.03.2024. Accepted for publication: 25.04.2024.
Medical Radiology and Radiation Safety. 2024. Vol. 69. № 4
DOI:10.33266/1024-6177-2024-69-4-62-70
L.I. Baranov, A.Yu. Bushmanov, N.A. Bogdanenko, A.N. Tsarev, A.S. Kretov,
I.G. Dibirgadzhiyev, T.M. Bulanova, Yu.E. Smirnov, A.S. Samoilov
Digital Twin as a Tool of Participatory Medicine for Workers of Nuclear Facility
A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: Л.И. Баранов, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
ABSTRACT
Introduction.
Рarticipatory medicine.
Health, norm.
Pre-shift medical examination of workers of nuclear facility as a source of significant individual health indicators.
Technological infrastructure for data collection.
The digital twin as a tool of participatory.
Protection of personal medical data.
Conclusion.
Keywords: participatory medicine, digital twin, worker of nuclear facility, pre-shift medical examination, medical information space
For citation: Baranov LI, Bushmanov AYu, Bogdanenko NA, Tsarev AN, Kretov AS, Dibirgadzhiyev IG, Bulanova TM, Smirnov YuE, Samoilov AS. Digital Twin as a Tool of Participatory Medicine for Workers of Nuclear Facility. Medical Radiology and Radiation Safety. 2024;69(4):62–70. (In Russian). DOI:10.33266/1024-6177-2024-69-4-62-70
References
1. URL: https://medvestnik.ru/content/news/Veronika-Skvorcova-obyavila-o-vstuplenii-v-eru-mediciny-4-P.html (Date of access: 12.03.2024) (In Russ.).
2. URL: https://doctorpiter.ru/novosti/minzdrav-soobshhil-o-nastuplenii-e-ry-mediciny-tri-p11352-id631498/ (Date of access: 12.03.2024) (In Russ.).
3. URL: https://chr.plus.rbc.ru/news/5bf80c387a8aa91a4c366622 (Date of access: 13.03.2024).
4. Ulyanov Yu.A. Zaripova E.M., Mingazova E.N. From Patient-Oriented Medicine to 4p Medicine: the Semantic Aspect of the Trend. Menedzher Zdravookhraneniya. 2020;9:26-29 (In Russ.).
5. Paltsev M.A. Medicina Budushchego. Personalizirovannaya Medicina: Opyt Proshlogo, Realii Zavtrashnego Dnya = Medicine of the Future. Personalized Medicine: the Experience of the Past, the Realities Of Tomorrow. Moscow Publ., 2020. 152 p. (In Russ.).
6. URL: http://www.consultant.ru/ (In Russ.).
7. Leroy Hood & Charles Auffray Participatory Medicine: a Driving Force for Revolutionizing Healthcare. Genome Medicine. 2013;5:110. doi:10.1186/gm514.
8. Epishkin N.I. Istoricheskiy Slovar’ Gallitsizmov Russkogo Yazyka = Historical Dictionary of Gallicisms of the Russian Language. Moscow Publ., 2010 (In Russ.).
9. URL: https://bigenc.ru/c/partisipativnost-4cfcc6 (Date of access: 12.03.2024) (In Russ.).
10. Kablashova I.V., Elfimova I.F., Logunova I.V. Theory of Management: the History of Managerial Thought. Voronezh State Technical University, 2013 (In Russ.).
11. Novikov D.A. Introductory Course of Lectures on the Theory of Management of Organizational Systems. Management of Large Systems: Proceedings. 2004;8:10-87 (In Russ.).
12. URL: http://government.ru/news/25907/ (Date of access: 12.03.2024) (In Russ.).
13. URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/037/137/original/План_мероприятий.pdf (Date of access: 12.03.2024) (In Russ.).
14. URL: https://ncmu.hse.ru/chelpoten_trends/participative_med. (Date of access: 12.03.2024) (In Russ.).
15. URL: https://бмэ.орг/index.php/ЗДОРОВЬЕ. (Date of access: 12.03.2024) (In Russ.).
16. URL: https://бмэ.орг/index.php/НОРМА. (Date of access: 12.03.2024) (In Russ.).
17. Krumlikova S.Y. Theoretical Approaches to the Interpretation of the Concept of «Human Health Norm». The Image of a Man of the Future: Whom and How to Educate in the Younger Generations. Ed. Bazaluk O.A. V. 1 Kiev Publ., 2011. P. 251-259.
18. Technologies for Performing Simple Medical Services of Functional Examination. GOST R 52623.1-2008 Is the National standard of the Russian Federation (In Russ.).
19. Quantifiedself URL: https://quantifiedself.com/ (Date of access: 13.03.2024).
20. Blood test variability // Quantifiedself URL: https://forum.quantifiedself.com/t/blood-test-variability/11783 (Date of access: 12.03.2024).
21. URL: https://kvzrm.ru/projects/tsifrovaya-platforma-monitoringa-zdorovya-na-aes-/ (Date of access: 12.03.2024). (In Russ.).
22. URL: https://kvzrm.ru/news/novosti/sovmestnoe-reshenie-tsifromed-i-esmo/ (Date of access: 12.03.2024). (In Russ.).
23. URL: https://vk.com/wall-155397808_146#:~:text=%20Цифровая%20платформа%20управления%20здоровьем, предприятия%20(ПАО%2C%20ДЗО%2C%20подрядные%20организации) (Date of access: 12.03.2024). (In Russ.).
24. URL: https://www.economy.gov.ru/material/departments/d31/koncepciya_gos_regulirovaniya_cifrovyh_platform_i_ekosistem/ (Date of access: 12.03.2024). (In Russ.).
25. URL: https://kvzrm.ru/news/novosti/distantsionnye-medosmotry-na-terminalakh-esmo/ (Date of access: 12.03.2024). (In Russ.).
26. On the Implementation of A Pilot Project for Remote Monitoring of the Patient’s Health Using the Information System (Platform) «Personal Medical Assistants». Decree of the Government of the Russian Federation dated 12/28/2022 No. 2469. URL: http://www.consultant.ru/ (In Russ.).
27. URL: https://minzdrav.gov.ru/news/2022/12/29/19716-v-rossii-startoval-pilotnyy-proekt-po-distantsionnomu-monitoringu-sostoyaniya-zdorovya-patsientov-s-ispolzovaniem-vysokotehnologichnyh-ustroystv-i-servisov. (Date of access: 12.03.2024). (In Russ.).
28. URL: https://www.cnews.ru/news/top/2023-02-14_sber_vyshel_na_rynok_meditsinskih (Date of access: 12.03.2024). (In Russ.).
29. URL: https://www.itmportal.ru/competition/sber-zdorovye.php (Date of access: 12.03.2024). (In Russ.).
30. URL: https://www.notebookcheck.net/Xiaomi-teases-new-ECG-and-blood-pressure-tracking-smartwatch.762134.0.html (Date of access: 12.03.2024).
31. URL: https://foresight-journal.hse.ru/data/2013/03/29/1294347383/6-vanRij-60-73.pdf. (Date of access: 13.03.2024). (In Russ.).
32. URL: https://minzdrav.gov.ru/news/2022/06/02/18814-pervyy-zamestitel-ministra-zdravoohraneniya-rossii-vladimir-zelenskiy-rasskazal-o-sozdanii-domena-zdravoohranenie (Date of access: 13.03.2023). (In Russ.).
33. URL: https://www.pnp.ru/social/v-rossii-poyavyatsya-cifrovye-dvoyniki-vrachey-i-pacientov.html (Date of access: 13.03.2024). (In Russ.).
34. URL: https://www.itmportal.ru/resources/presentations/domen-zdravookhranenie-proektirovanie-i-razvitie/ (Date of access: 13.03.2024). (In Russ.).
35. URL: https://www.comnews.ru/content/229476/2023-10-17/2023-w42/1007/zdorove-eksport-rossii-poyavyatsya-cifrovye-profili-pacientov-kotorye-budut-obuchat-ii. (Date of access: 13.03.2024). (In Russ.).
36. URL: https://ria.ru/20240220/transformatsiya-1928492156.html. (Date of access: 13.03.2023). (In Russ.).
37. Baranov L.I. The Digital Double as a Product of the Information Society. New Opportunities for Research in the Field of Medical Radiology. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2022;67;6:86–95. DOI:10.33266/1024-6177-2022-67-6-86-95. (In Russ.).
38. Baranov L.I., Tsarev A.N., Torubarov F.S., Kretov A.S., Petrova V.V., Vasiliev A.V., Dumansky S.M., Tikhonova O.A., Bulanova T.M., Kalinina M.V., Shulepov P.A., Dibirgadzhiev I., Samoilov A.S. Digital Twin of Worker of Nuclear Facility at the Stage Pre-Shift Control. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost = Medical Radiology and Radiation Safety. 2024;69;1:С. 33–40. DOI:10.33266/1024-6177-2024-69-1-33-40. (In Russ.).
39. URL: https://minzdrav.gov.ru/news/2021/06/04/16781-mihail-murashko-neobhodimo-sozdat-tsifrovoy-profil-zdorovya-dlya-kazhdogo-cheloveka. (Date of access: 13.03.2023). (In Russ.).
40. URL: https://www.itmportal.ru/upload/iblock/4db/9oiiw45cs0fvj49rf7xy0j5wpu2t7upu/1.8.1-Artemova-Federalnyi_proekt_Personalnye_meditsinskie_pomoshchniki_1.pdf. (Date of access: 13.03.2023). (In Russ.).
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.03.2024. Accepted for publication: 25.04.2024.
Medical Radiology and Radiation Safety. 2024. Vol. 69. № 4
DOI:10.33266/1024-6177-2024-69-4-77-80
A.P. Dunaev1, 2, 3, A.N. Bashkov3, 4, Zh.V. Sheikh3, 5, 6, E.V. Esin3,
I.V. Shipuleva1, M.V. Popov4, T.Yu. Kudryavtseva1, O.V. Lazebnaya1
CT and MRI in the Diagnostics of Intrahepatic Portocaval Shunt.
Review of Lite rature and Case Reports
1 Moscow City Oncology Hospital No. 62, Moscow, Russia
2 Central State Medical Academy, Moscow, Russia
3 Russian University of People’s Frendship, Moscow, Russia
4 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
5 S.P. Botkin City Clinical Hospital, Moscow, Russia
6 Russian Medical Academy of Postgraduate Education, Moscow, Russia
Contact person: A.P. Dunaev, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: To describe two cases of diagnostic of intrahepatic portacaval shunt based on the computed (CT) and magnetic resonance tomography (MRI). Provide a brief review of the literature on this pathology.
Material and methods: Two case reports of patients with intrahepatic portacaval shunts which were diagnosed by CT and MRI with contrast enhancement.
Results and discussion: A peculiarity of the presented case reports was that in both cases the patients had oncopathology and were examined for the purpose of staging the disease. Due to the risk of cancer when analyzing CT and MRI images, focal changes in the liver can be mistakenly interpreted as metastases. In various situations, the attending physician may choose tactics for further observation, or decide to verify the identified changes in the liver. In the latter case, minimally invasive intervention can damage the shunt wall and cause bleeding. To avoid any complications, the radiologist have to identify and interpret vascular abnormalities in the liver confidently and unambiguously. The two presented case reports demonstrated typical signs of an intrahepatic porthocaval shunt, both according to CT and MRI. These include the connection of the lesion with the main vessels with similar dynamics of contrast enhancement, and the absence of signs of diffusion restriction.
Conclusion: The presented semiotics of the intrahepatic portacaval shunt according to CT and MRI data allows to diagnose it confidently and thus avoid the need for repeated studies or surgical intervention.
Keywords: computed tomography, magnetic resonance imaging, intrahepatic portocaval shunt
For citation: Dunaev AP, Bashkov AN, Sheikh ZhV, Esin EV, Shipuleva IV, Popov MV, Kudryavtseva TYu, Lazebnaya OV. CT and MRI in the Diagnostics of Intrahepatic Portocaval Shunt. Review of Literature and Case Reports. Medical Radiology and Radiation Safety. 2024;69(4):77–80. (In Russian). DOI:10.33266/1024-6177-2024-69-4-77-80
References
1. Brown K.M., Hal H. Asymptomatic Congenital Intrahepatic Portosystemic Shunt. Radiology Case Reports. 2009;4:255.
2. Remer E.M., Motta-Ramirez G.A., Henderson J.M. Imaging Findings in Incidental Intrahepatic Portal Venous Shunts. AJR Am J Roentgenol. 2007;188;2:W162-167. doi: 10.2214/AJR.05.1115.
3. Tsitouridis I., Sotiriadis C., Michaelides M., Dimarelos V., Tsitouridis K., Stratilati S. Intrahepatic Portosystemic Venous Shunts: Radiological Evaluation. Diagn Interv Radiol. 2009;15:182–187.
4. Murray C.P., Yoo S.J., Babyn P.S. Congenital Extrahepatic Portosystemic Shunts. Pediatr Radiol. 2003;33:614–620.
5. Park J.H., Cha S.H., Han J.K., Han M.C. Intrahepatic Portosystemic Venous Shunt. AJR Am. J. Roentgenol. 1990;155;3:527-528. doi: 10.2214/ajr.155.3.2117349.
6. Ramanathan S., Raghu V., Virmani V., Sheikh A., Al Heidous M., Tirumani S. Unveiling the Unreal: Comprehensive Imaging Review of Hepatic Pseudolesions. Clin Imaging. 2021;80:439-453. doi: 10.1016/j.clinimag.2021.09.008.
7. Кармазановский Г.Г. Роль МСКТ и МРТ в диагностике очаговых заболеваний печени // Анналы хирургической гепатологии. 2019. Т.24, № 4. С. 91-110. [Karmazanovskiy G.G. The Role of MDCT and MRI in the Diagnosis of Focal Liver Diseases. Annaly Khirurgicheskoy Gepatologii = Annals of HPB Surgery. 2019;24;4:91-110. (In Russ.)]. https://doi.org/10.16931/1995-5464.2019491-110.
8. Башков А.Н., Шейх Ж.В., Восканян С.Э., Дунаев А.П., Попов М.В., Удалов Ю.Д., Самойлов А.С. Возможность снижения лучевой нагрузки на пациентов за счет оптимизации протокола компьютерной томографии органов брюшной полости и забрюшинного пространства в зависимости от нозологии злокачественного процесса // Радиационная гигиена. 2019. Т.12, № 3. С. 6-15. [Bashkov A.N., Sheykh Zh.V., Voskanyan S.E., Dunaev A.P., Popov M.V., Udalov Yu.D., Samoylov A.S. Prospects for the Reduction of the Patient Doses Based on the Optimization of the CT Abdomen Protocols for the Different Types of Malignancies. Radiatsionnaya Gygiena = Radiation Hygiene. 2019;12;3:6-15 (In Russ.)]. https://doi.org/10.21514/1998-426X-2019-12-3-6-15.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.03.2024. Accepted for publication: 25.04.2024.
Medical Radiology and Radiation Safety. 2024. Vol. 69. № 4
DOI:10.33266/1024-6177-2024-69-4-71-76
E.I. Matkevich1, 2, Е.А. Ladik1, E.V. Bril1, O.S. Zimnyakova1, V.V. Bryukhov3
Assessment of Midbrain Structure Visualization with Modified 3 Tesla MRI Protocols for Enhanced Parkinson’s Disease Diagnosis
1 A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
2 RUDN University, Moscow, Russia
3 Research Center of Neurology, Moscow, Russia
Contact person: E.I. Matkevich, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpose: To assess the outcomes and implications of modifying SWAN protocol parameters on a 3 Tesla MRI for midbrain structure imaging in patients to detect signs of Parkinson’s disease.
Material and methods: The study was conducted on 22 patients of both genders, ranging in age from 30 to 77 years. Protocols for the standard MRI brain examination and its two variations in the SWAN program, which involved reducing the slice thickness, were analyzed. Key parameters for the visualization of midbrain structures were identified, and subsequently evaluated by expert radiologists.
Results: Parameters within the SWAN protocol for MRI scanning were identified, the modification of which enhances the clarity of nigrosome-1 visualization. It was established that thin-slice modifications of the brain scanning protocols (slice thicknesses of 1.2 and 2 mm) reveal early, diagnostically significant features of nigrosome-1 for Parkinson’s disease 3.4 to 4.1 times more frequently than the standard survey protocol with a slice thickness of 4 mm.
Conclusion: The significance of selecting appropriate MRI protocol parameters for studying midbrain structures to enhance the visualization effectiveness of nigrosome-1 has been confirmed. Employing the SWAN sequence on a 3 Tesla MRI scanner with a slice thickness of 2 mm or less in a neurological department setting during routine Parkinson’s disease examinations achieves superior imaging results compared to conventional survey MRI protocols with a 4 mm slice thickness. This approach demonstrates high inter-rater reliability and aligns with European recommendations for neuroimaging.
Keywords: radiation diagnostics, 3 Tesla MRI, substantia nigra, Parkinson’s disease, nigrosome-1, inter-rater agreement
For citation: Matkevich EI, Ladik ЕА, Bril EV, Zimnyakova OS, Bryukhov VV. Assessment of Midbrain Structure Visualization with Modified 3 Tesla MRI Protocols for Enhanced Parkinson’s Disease Diagnosis. Medical Radiology and Radiation Safety. 2024;69(4):71–76. (In Russian). DOI:10.33266/1024-6177-2024-69-4-71-76
References
1.GBD 2016. Neurology Collaborators. Global, Regional, and National Burden of Neurological Disorders, 1990-2016: a Systematic Analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18;5:459-480. doi: 10.1016/S1474-4422(18)30499-X.
2.Khan A.Z., Lavu D., Neal R.D. Parkinson’s Disease: a Scoping Review of the Quantitative and Qualitative Evidence of Its Diagnostic Accuracy in Primary Care. Br J Gen Pract. 2024;27;74;741:e227-e232. doi: 10.3399/BJGP.2023.0409.
3.Li T., Le W. Biomarkers for Parkinson’s Disease: How Good Are They? Neurosci Bull. 2020;36;2:183-194. doi: 10.1007/s12264-019-00433-1.
4.Aludin S., Schmill L.A. MRI Signs of Parkinson’s Disease and Atypical Parkinsonism. Fortschr Röntgenstr 2021;193: 1403 – 1410.
5.Diagnostic Imaging: Brain. Ed. Anne G. Osborn, Karen L. Salzman, Miral D. Jhaveri. Third Publisher: Elsevier. 2016. ISBN 978-0-323-37754-6.
6.Gramsch C., Reuter I., Kraff O. Nigrosome 1 Visibility at Susceptibility Weighted 7T MRI ‒ a Dependable Diagnostic Marker for Parkinson’s Disease or Merely an Inconsistent Age-Dependent Imaging Finding? Plos One 2017;12:e0185489. doi: 10.1371/journal.pone.0185489.
7.Litvinenko I.V., Krasakov I.V., Trufanov A.G. Cerebral Disorders of Iron Metabolism as the Basis of the Development and Progression of Neurodegenerative Diseases. Vestnik Rossiyskoy Voyenno-Meditsinskoy Akademii = Bulletin of the Russian Military Medical Academy. 2018;20;3S:68-78 (In Russ.).
8.Andropova P.L., Gavrilov P.V., Kazantseva I.P., Kochanova N.I., Narkevich A.N., Trofimova T.N. Interexpert Agreement Between Emergency Neuroradiologists with Different Levels of Experience in the Rating of ASPECTS. Radiologiya – Praktika = Radiology – Practice. 2022;5:10-25. https://doi.org/10.52560/2713-0118-2022-5-10-25. (In Russ.).
9.Moskalenko A.N., Filatov A.S., Fedotova E.Y., Konovalov R.N., Illarioshkin S.N. Visual Analysis of Nigrosome-1 in the Differential Diagnosis of Parkinson’s Disease and essential Tremor. Bulletin of RSMU. 2022;1:47–52. doi: 10.24075/brsmu.2022.002. (In Russ.).
10.Barkhof F., Jäger H.R., Thurnher M.M., Rovira Àlex. Clinical Neuroradiology (The ESNR Textbook). 2019. doi: 10.1007/978-3-319-68536-6.
11.Haller S., Haacke E.M., Thurnher M.M., Barkhof F. Susceptibility-Weighted Imaging: Technical Essentials and Clinical Neurologic Applications. Radiology. 2021;299;1:3-26. doi: 10.1148/radiol.2021203071.
12.Arnaldi D., Morbelli S., Picco A., Ferrara M., Buschiazzo A., Famà F., De Carli F., Nobili F. Functional Imaging in Pre-Motor Parkinson’s Disease. Q J Nucl Med Mol Imaging. 2014;58;4:366-375.
13.Kim E.Y., Sung Y.H., Lee J. Nigrosome 1 Imaging: Technical Considerations and Clinical Applications. Br J Radiol. 2019;92;1101:20180842. doi: 10.1259/bjr.20180842.
14. Cheng Z., He N., Huang P., Li Y., Tang R., Sethi S.K., Ghassaban K., Yerramsetty K.K., Palutla V.K., Chen S., Yan F., Haacke E.M. Imaging the Nigrosome 1 in the Substantia Nigra Using Susceptibility Weighted Imaging and Quantitative Susceptibility Mapping: An Application to Parkinson’s Disease. Neuroimage Clin. 2020;25:102103. doi: 10.1016/j.nicl.2019.102103.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.03.2024. Accepted for publication: 25.04.2024.
Medical Radiology and Radiation Safety. 2024. Vol. 69. № 4
DOI:10.33266/1024-6177-2024-69-4-81-87
Е.А. Rasskazova 1, A.D. Zikiryakhodzhaev 1-3
Results of Treatment of Patients with Stage I‒Ii Breast Cancer after Subcutaneous/Skin-Preserving Mastectomies with Reconstruction with/without Radiation Therapy
1 P.A. Hertsen Moscow Oncology Research Institute, Moscow, Russia
2 I.M. Sechenov First Moscow State Medical University, Moscow, Russia
3 People’s Friendship University of Russia, Moscow, Russia
Contact person: E.A. Rasskazova, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Abstract
Purpos: To study the oncological results and features of complications in patients with breast cancer in stages I‒II after subcutaneous/skin-preserving mastectomies with reconstruction with/without radiation therapy.
Material and methods: From 2013 to 2022, 984 breast cancer patients underwent 1020 subcutaneous/skin-preserving mastectomies with simultaneous one- or two-stage reconstruction at the Herzen Moscow Medical Research Institute.
Subcutaneous mastectomy with reconstruction was performed in 617 (60.5 %), skin-preserving mastectomy in 403 (39.5 %) cases.
Reconstruction with the patient’s own tissues was performed in 5.7 %, expanders/implants in 94.3 % of patients.
Results: The recurrence rate of breast cancer was 41 (4.2±0.6 %), the frequency of distant metastases was diagnosed in 53 (5.4±0.7 %) in the studied group of patients.
Complications were diagnosed in 241 (24.5 %) patients.
Recurrence in the group with radiation therapy was 2.6±0.6 (OR 0.98, CI 1.52‒3.48, 95 %), without radiation therapy 5.9 % (OR 2.13, CI 0.92‒5.18, 95 %) regardless of the stage of breast cancer (criterion T > 2, p ˂ 0,05).
Capsular contracture (CC) of the III‒IV degree was diagnosed in 9.4 % of the analyzed group of patients.
Capsular contracture of the III‒IV degree worsens the aesthetic result of breast reconstruction, as well as reduces the quality of life of patients. With simultaneous two–stage reconstruction, the risk of developing CC was 4.2 % (after LT 4.7 %, without LT 3.6 %), with one-stage reconstruction, the risk of developing CC 11.2 % (after LT 15.8 %, without LT 4 %).
In the study group of patients, the effect of LT on the risk of CC was 12.6 %, without LT 3.7 % (p < 0.05), the difference is statistically significant.
In our study, the recurrence of breast cancer at the edge of R1 was 6.8±2.5 %, at R0 – 3±0.6 % (p > 0.05).
When analyzing the age and risk of recurrence, we did not identify an age dependence, before 40 years the probability of recurrence was 4.3±1 %, after 40 years – 3.3±0.7 % (criterion T = 0.44, p > 0.05).
A statistically significant difference in our study was revealed, except for radiation therapy, during NAPHT, thus, in the group with NAPHT, the recurrence was 2.4± 0.8 %, without NAPHT – 4.6±0.7 % (criterion T = 2.16, p ˂ 0.05).
When performing a simultaneous two-stage reconstruction of a patient with the inclusion of radiation therapy (LT), the risk of skin protrusion was 18 %, without radiation therapy – 8.3 %.
Capsular contracture (CC) of the III‒IV degree was diagnosed in 9.4 % of the analyzed group of patients.
Capsular contracture of the III‒IV degree worsens the aesthetic result of breast reconstruction, as well as reduces the quality of life of patients. With simultaneous two–stage reconstruction, the risk of developing CC was 4.2 % (after LT 4.7 %, without LT 3.6 %), with one-stage reconstruction, the risk of developing CC 11.2 % (after LT 15.8 %, without LT 4 %).
In the study group of patients, the effect of LT on the risk of CC was 12.6 %, without LT 3.7 % (p < 0.05), the difference is statistically significant.
Keywords: breast cancer, recurrence, skin-preserving mastectomies, subcutaneous mastectomies, radiation therapy, reconstruction, implants, protrusion, capsular contracture
For citation: Rasskazova ЕА, Zikiryakhodzhaev AD. Results of Treatment of Patients with Stage I‒Ii Breast Cancer after Subcutaneous/Skin-Preserving Mastectomies with Reconstruction with/without Radiation Therapy. Medical Radiology and Radiation Safety. 2024;69(4):81–87. (In Russian). DOI:10.33266/1024-6177-2024-69-4-81-87
References
1. Каприн А.Д., Старинский В.В., Шахзадова А.О. Состояние онкологической помощи населению России в 2022 году. М.: МНИОИ им. П.А. Герцена, 2022. 239 с. [Kaprin A.D., Starinskiy V.V., Shahzadova A.O. Sostoyanie Onkologicheskoy Pomoshchi Naseleniyu Rossii v 2022 godu = The State of Cancer Care for the Population of Russia in 2022. Moscow, MNIOI im. P.A.Gertsena Publ., 2022. 239 p. (In Russ.)].
2. Демидов С.М., Демидов Д.А., Сазонов С.В., Чуракова Е.И. Иммуногистохимические характеристики рака молочной железы, увеличивающие риск локального рецидива после органосохраняющего лечения // Опухоли женской репродуктивной системы. 2018. Т.15, №3. С. 10–14 [Demidov S.M., Demidov D.A., Sazonov S.V., Churakova E.I. Immunohistochemical Characteristics of Breast Cancer that Increase the Risk Of Local Recurrence after Breast-Conserving Treatment. Opukholi Zhenskoy Reproduktivnoy Sistemy = Tumors of the Female Reproductive System. 2018;15(3):10–4 (In Russ.)].
3. Дружков М.О., Гатауллин И.Г., Дружков О.Б. Динамика иммунофенотипа рака молочной железы от первичной опухоли к локальному рецидиву // Онкохирургия. 2011. Т. 3, № 2. С. 26. [Druzhkov M.O., Gataullin I.G., Druzhkov O.B. Dynamics of the Immunophenotype of Breast Cancer from the Primary Tumor to Local Relapse. Onkokhirurgiya = Oncosurgery. 2011;3;2:26 (In Russ.)].
4. Малыгин С.Е., Малыгин Е.Н., Петерсон С.Б. Местные и региональные рецидивы после мастэктомии с одномоментной реконструкцией при раке молочной железы // Вестник Российского государственного медицинского университета. 2013. № 4. С. 24-27 [Malygin S.E., Malygin E.N., Peterson S.B. Local and Regional Relapses after Mastectomy with Simultaneous Reconstruction for Breast Cancer. Vestnik Rossiyskogo Gosudarstvennogo Meditsinskogo Universiteta = Bulletin of the Russian State Medical University. 2013;4:24-27 (In Russ.)].
5. Wu ZY, Han HH, Han J, Kim HJ, Lee J, Chung IY, Kim J, Lee S, Eom JS, Kim SB, Gong G, Kim HH, Son BH, Ahn SH, Ko B. Impact of Local Breast Cancer Recurrence on Reconstructed Breast in Nipple-Sparing Mastectomy with Immediate Reconstruction. J Plast Reconstr Aesthet Surg. 2022 Aug;75(8):2535-2541. doi: 10.1016/j.bjps.2021.05.030.
6. Vuong B, Darbinian J, Savitz A, Odele P, Perry LM, Sandhu L, Habel LA, Kuehner G. Breast Cancer Recurrence by Subtype in a Diverse, Contemporary Cohort of Young Women. J Am Coll Surg. 2023 Jul 1;237(1):13-23. doi: 10.1097/XCS.0000000000000714.
7. Christopher AN, Morris MP, Jia H, Patel V, Broach RB, Serletti JM, Fosnot J. Managing Locoregional Breast Cancer Recurrence after Autologous Free Flap Reconstruction: A Retrospective Review of 2,734 Procedures. J Plast Reconstr Aesthet Surg. 2022 Feb;75(2):562-570. doi: 10.1016/j.bjps.2021.09.078.
8. Woodward S, Willis A, Lazar M, Berger AC, Tsangaris T. Nipple-Sparing Mastectomy: a Review of Outcomes at a Single Institution. Breast J. 2020 Nov;26(11):2183-2187. doi: 10.1111/tbj.14088.
9. Adra J, Lundstedt D, Killander F, Holmberg E, Haghanegi M, Kjellén E, Karlsson P, Alkner S. Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes. Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):285-295. doi: 10.1016/j.ijrobp.2019.06.013.
10. Wang J, Luo J, Jin K, Wang X, Yang Z, Ma J, Mei X, Wang X, Zhou Z, Yu X, Chen X, Guo X. Biological Subtype Predicts Locoregional Recurrence after Postmastectomy Radiotherapy in Chinese Breast Cancer Patients. Cancer Med. 2020 Apr;9(7):2427-2434. doi: 10.1002/cam4.2904.
11. Chen SY, Sun GY, Tang Y, Jing H, Song YW, Jin J, Liu YP, Zhao XR, Song YC, Chen B, Qi SN, Tang Y, Lu NN, Li N, Fang H, Li YX, Wang SL. Timing of Postmastectomy Radiotherapy Following Adjuvant Chemotherapy for High-Risk Breast Cancer: a Post Hoc Analysis of a Randomised Controlled Clinical Trial. Eur J Cancer. 2022 Oct;174:153-164. doi: 10.1016/j.ejca.2022.07.023.
12. Jagsi R, Barlow WE, Woodward WA, Connolly E, Mahtani R, Shumway D, Speers C, Stecklein SR, Zeidan Y, Zhang H, Sharma P, Pusztai L, Hortobagyi GN, Kalinsky K. Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial. JAMA Oncol. 2023 Aug 1;9(8):1083-1089. doi: 10.1001/jamaoncol.2023.1984.
13. Kim D, Kim JH, Kim IA, Chang JH, Shin KH. Impact of Postmastectomy Radiation Therapy on Breast Cancer Patients According to Pathologic Nodal Status after Modern Neoadjuvant Chemotherapy. Cancer Res Treat. 2023 Apr;55(2):592-602. doi: 10.4143/crt.2022.998.
14. Brett JO, Mayer EL. New Developments in Systemic Management for High-Risk Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer. Curr Treat Options Oncol. 2023 Jun;24(6):594-610. doi: 10.1007/s11864-023-01082-3.
15. Chen BF, Tsai YF, Lien PJ, Lin YS, Feng CJ, Chen YJ, Cheng HF, Tseng LM, Huang CC. Clinical Characteristics and Treatment Outcomes of Invasive Ductal and Lobular Carcinoma: Analyses of 54,832 Taiwan Cancer Registry Index Cases. Breast Cancer Res Treat. 2023 Oct;201(3):547-560. doi: 10.1007/s10549-023-07044-5.
16. Рак молочной железы: Клинические рекомендации. М.: Минздрав России, 2021-2023. 94 с. [Rak Molochnoj Zhelezy. Klinicheskie Rekomendatsii = Breast Cancer: Clinical Recommendations. Moscow, Minzdrav Rossii Publ., 2021-2023. 94 p. (In Russ.)].
17. Eichler C, Schulz C, Thangarajah F, Malter W, Warm M, Brunnert K. A Retrospective Head-to-head Comparison Between TiLoop Bra/TiMesh® and Seragyn® in 320 Cases of Reconstructive Breast Surgery. Anticancer Res. 2019 May;39(5):2599-2605. doi: 10.21873/anticanres.13383. PMID: 31092458.
18. Kim JH, Chun YS, Park HK, Kim SE, Kim YW, Cheon YW. Inframammary Fold Incision Can Reduce Skin Flap Necrosis in Immediate Breast Reconstruction With Implant and Conjoined Fascial Flap. Ann Plast Surg. 2020 Nov;85(5):488-494. doi: 10.1097/SAP.0000000000002393. PMID: 32332387
19. Vaccari S, Klinger F, Sciretta AP, Di Giuli R, Bandi V, Veronesi A, Catania B, Klinger M, Vinci V. Implant-Based Breast Reconstruction: Impact of Body Mass Index on Postoperative Complications and Aesthetic Results: A 5-Year, Single-Center Study. Aesthet Surg J. 2023, 16 Now; 43(12): NP1063-NP1070. doi: 10.1093/asj/ sjad289. PMID: 37658866.
20. Zheng C, Liu J, Wen Y, Lin S, Han H, Xu C. A Systematic Review and Meta-Analysis of Postmastectomy Radiation Therapy on Prepectoral Versus Subpectoral Breast Reconstruction. Front Surg. 2023 Jan 9;9:1019950. doi: 10.3389/fsurg.2022.1019950. PMID: 36700017; PMCID: PMC9869385.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Rasskszova A.E. ‒ idea and design of the trial; Zikiryakhodzhaev A.D. – reviewing.
Article received: 20.03.2024. Accepted for publication: 25.04.2024.